255 related articles for article (PubMed ID: 26769276)
1. Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity.
Colonna L; Parry GC; Panicker S; Elkon KB
Clin Immunol; 2016 Feb; 163():84-90. PubMed ID: 26769276
[TBL] [Abstract][Full Text] [Related]
2. C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells.
Fraser DA; Laust AK; Nelson EL; Tenner AJ
J Immunol; 2009 Nov; 183(10):6175-85. PubMed ID: 19864605
[TBL] [Abstract][Full Text] [Related]
3. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
Gullstrand B; Mårtensson U; Sturfelt G; Bengtsson AA; Truedsson L
Clin Exp Immunol; 2009 May; 156(2):303-11. PubMed ID: 19302245
[TBL] [Abstract][Full Text] [Related]
4. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
5. C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity.
Gershov D; Kim S; Brot N; Elkon KB
J Exp Med; 2000 Nov; 192(9):1353-64. PubMed ID: 11067883
[TBL] [Abstract][Full Text] [Related]
6. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation.
Xu W; Berger SP; Trouw LA; de Boer HC; Schlagwein N; Mutsaers C; Daha MR; van Kooten C
J Immunol; 2008 Jun; 180(11):7613-21. PubMed ID: 18490764
[TBL] [Abstract][Full Text] [Related]
7. Human complement Factor H modulates C1q-mediated phagocytosis of apoptotic cells.
Kang YH; Urban BC; Sim RB; Kishore U
Immunobiology; 2012 Apr; 217(4):455-64. PubMed ID: 22088229
[TBL] [Abstract][Full Text] [Related]
8. C1 subcomponent complexes: basic and clinical aspects.
Laurell AB; Sjöholm AG
Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
[TBL] [Abstract][Full Text] [Related]
9. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement.
Bijl M; Reefman E; Horst G; Limburg PC; Kallenberg CG
Ann Rheum Dis; 2006 Jan; 65(1):57-63. PubMed ID: 15919679
[TBL] [Abstract][Full Text] [Related]
10. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance.
Roumenina LT; Sène D; Radanova M; Blouin J; Halbwachs-Mecarelli L; Dragon-Durey MA; Fridman WH; Fremeaux-Bacchi V
J Immunol; 2011 Oct; 187(8):4369-73. PubMed ID: 21930969
[TBL] [Abstract][Full Text] [Related]
11. Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.
Donat C; Thanei S; Trendelenburg M
Front Immunol; 2019; 10():2712. PubMed ID: 31824501
[TBL] [Abstract][Full Text] [Related]
12. Anti-C1s humanized monoclonal antibody SAR445088: A classical pathway complement inhibitor specific for the active form of C1s.
Simmons KT; Chan J; Hussain S; Rose EL; Markham K; Byun TS; Panicker S; Parry GC; Storek M
Clin Immunol; 2023 Jun; 251():109629. PubMed ID: 37149117
[TBL] [Abstract][Full Text] [Related]
13. Antibody-mediates inhibition of human C1s and the classical complement pathway.
Carroll S; Georgiou G
Immunobiology; 2013 Aug; 218(8):1041-8. PubMed ID: 23434433
[TBL] [Abstract][Full Text] [Related]
14. The regulatory roles of C1q.
Lu J; Wu X; Teh BK
Immunobiology; 2007; 212(4-5):245-52. PubMed ID: 17544810
[TBL] [Abstract][Full Text] [Related]
15. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.
Nauta AJ; Trouw LA; Daha MR; Tijsma O; Nieuwland R; Schwaeble WJ; Gingras AR; Mantovani A; Hack EC; Roos A
Eur J Immunol; 2002 Jun; 32(6):1726-36. PubMed ID: 12115656
[TBL] [Abstract][Full Text] [Related]
16. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells.
Nauta AJ; Castellano G; Xu W; Woltman AM; Borrias MC; Daha MR; van Kooten C; Roos A
J Immunol; 2004 Sep; 173(5):3044-50. PubMed ID: 15322164
[TBL] [Abstract][Full Text] [Related]
17. Complement C1s as a diagnostic marker and therapeutic target: Progress and propective.
Ye J; Yang P; Yang Y; Xia S
Front Immunol; 2022; 13():1015128. PubMed ID: 36275687
[TBL] [Abstract][Full Text] [Related]
18. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
19. C1q protein binds to the apoptotic nucleolus and causes C1 protease degradation of nucleolar proteins.
Cai Y; Teo BH; Yeo JG; Lu J
J Biol Chem; 2015 Sep; 290(37):22570-80. PubMed ID: 26231209
[TBL] [Abstract][Full Text] [Related]
20. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
